PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAD8W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $100,801
Award facts
- Contract value 100% obligated
- $100,800.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on December 15, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) carries a ceiling value of $100,800.96 and represents a firm fixed-price acquisition under the Defense Logistics Agency's Medical Supply Chain program. The award is non-competitive and performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. As a child contract, this delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical support vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing a comprehensive portfolio of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Under the SPE2DX IDC, the company supplies pharmaceutical products spanning multiple therapeutic domains—including specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities. The firm's track record of competitively awarded contracts demonstrates its established capability to fulfill federal medical procurement requirements. The Defense Logistics Agency plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the strategic vendors supporting DoD and federal healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2D826FAD8W?
SPE2D826FAD8W was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 15, 2025.
How much is contract SPE2D826FAD8W worth?
The government has obligated $100,801 on SPE2D826FAD8W.
Is contract SPE2D826FAD8W an order under another contract?
Yes. SPE2D826FAD8W is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAD8W competed?
The extent of competition for SPE2D826FAD8W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award